SCIENCE WORLD JOURNAL OF PHARMACEUTICAL SCIENCES最新文献

筛选
英文 中文
Case Report on Perthes Disease in 9 Year Male Child 9岁男童柏蒂斯病1例报告
SCIENCE WORLD JOURNAL OF PHARMACEUTICAL SCIENCES Pub Date : 1900-01-01 DOI: 10.47690/SWJPS.2020.2201
R. Tiwari, Suraj Sandil, Parminder Nain, Jaspreet Kaur, A. Yadav
{"title":"Case Report on Perthes Disease in 9 Year Male Child","authors":"R. Tiwari, Suraj Sandil, Parminder Nain, Jaspreet Kaur, A. Yadav","doi":"10.47690/SWJPS.2020.2201","DOIUrl":"https://doi.org/10.47690/SWJPS.2020.2201","url":null,"abstract":"Perthes disease is a hip joint disease usually occurring in children due to lack of blood supply to the bone. The disease is more commonly seen in male child as compared female child the cause is not known, symptoms usually occur when the disease reaches in later stage, the diagnosis is usually confirmed by radiological investigation X-ray and MRI. It is also seen bilaterally. The disease occurs in young children so any children complaining of hip or joint bone pain in lower limb should always be considered or perthes should be ruled out. The early stage may not be seen in radiological investigation sometimes infection and trauma may also present with the same kind of symptoms. INTRODUCTION Perthes disease is defined as the disease of the hip joint in children, where the blood supply to the hip and bone is hampered which ultimately leads to bone death [1]. The bone becomes weak and small break (fracture) develops due to lack of supply of blood in the bone [2]. This causes changes shape of the bone so that it no longer fits into the hip joint socket properly [1]. The blood supply returns after several months [2]. Without treatment, the head ofthe femur flattens causing pain in the hip, a limp and arthritis in later years [3]. The cause of perthes disease is not known [3]. Perthes disease occurs in children between 2 to 10 years of age [4]. It occurs 4 times more in boy as compared to girl and is associated with a low birth weight, especially boys less than 5.5 pounds [5]. Symptoms do not occur in early stages of perthes disease [4]. The symptoms are knee pain, stiffness, limp, child’s movements are reduced, smaller the muscle of the affected leg etc. Perthes disease usually affects one hip [4]. About 1 in 5 children with Perthes disease have the disease in both hips [6]. X-ray is helpful in diagnosis of perthes disease [6]. In the early stages X-ray may not helpful as the signs of the disease may not have appeared [5]. Magnetic resonance images (MRI) can be used to detect the amount of blood supply in the head of the femur and confirm the diagnosing [7]. CASE REPORT We present the case of a 9 year male child was brought to the emergency departmentby his parents complained of inability to bear weight on left leg and pain in left hip since one day. There was a history of on and off pain in left hip since 5 to 6 months. There was no history of trauma and nothing of note in his medical history other than recent Coryzal symptoms. On examination: the child was afebrile with stable vital signs, SLR (Lasegue’s sign) of the right leg is 70° and left leg is unable to perform, no redness and other signs of local inflammation, no scars, tenderness present. Left knee and left ankle are within normal limit.The blood samplewas taken in the emergency department and revealed a mildly raised erythrocyte sedimentation rate (ESR) of 12 mm/h. All other blood testsincluding full blood count, C-reactive protein and bone profile were normal. Ultrasonography of the hip sh","PeriodicalId":109285,"journal":{"name":"SCIENCE WORLD JOURNAL OF PHARMACEUTICAL SCIENCES","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114198903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Studies on In Vitro and In Vivo Antioxidant Evaluation and Total Phenolic, Flavonoidal ContentEstimation of Beta vulgaris root 甜菜根体外、体内抗氧化评价及总酚、黄酮含量测定研究
SCIENCE WORLD JOURNAL OF PHARMACEUTICAL SCIENCES Pub Date : 1900-01-01 DOI: 10.47690/swjps.2019.1102
Nwaogwugwu Cj, Nosiri Ci, Atasie Oc, Nwadike C
{"title":"Studies on In Vitro and In Vivo Antioxidant Evaluation and Total Phenolic, Flavonoidal ContentEstimation of Beta vulgaris root","authors":"Nwaogwugwu Cj, Nosiri Ci, Atasie Oc, Nwadike C","doi":"10.47690/swjps.2019.1102","DOIUrl":"https://doi.org/10.47690/swjps.2019.1102","url":null,"abstract":"Beta vulgaris root extracts are traditionally used as a folk medicine to treatailments such ashypertension, hypoglycemic, inflammatory, and hepertocellular disorder. In this study the antioxidant potential of root extract of B. vulgaris were mentored invitroagainst 2, 2-diphenyl-1-pic-rylhydrazyl (DPPH) and modulatory effect on rat brain enzymes.Total phenolic, flavonoid contents, and antioxidant potential against DPPH of the root extracts at varying concentrations were evaluatedusing ethyl acetate. Thus concentration of root extracts of B. vulgaris root at100, 200, and 400 mg/kg body weights were administered orally for (7)days to albino rats followed byevaluated of oxidative stress markers such as thiobarbituric acid reactive substances (TBARS), Superoxide Dismutase (SOD), Catalase (CAT), and Glutathione (GSH) in the animals brain ho -mogenate.The percentage inhibition and IC50 value ofthe root extracts were significantly (P < 0.01) dose dependent compared to ascorbic acid standard. Similarly SOD, CAT, and GSHincreased significantly (P < 0.01) in test animals administered200 and 400 mg/kg of ethyl acetate extract of B. vulgaris root. The results obtained here suggest thatB. vulgaris roots extracts suggests a neuroprotective potential of this plant roots.","PeriodicalId":109285,"journal":{"name":"SCIENCE WORLD JOURNAL OF PHARMACEUTICAL SCIENCES","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114397935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of In Vitro Anthelmintic Activity of Sesbania aculeata 田菁体外驱虫活性评价
SCIENCE WORLD JOURNAL OF PHARMACEUTICAL SCIENCES Pub Date : 1900-01-01 DOI: 10.47690/swjps.2019.1103
I. Srikanth, K. Sai, G. Srihari, Dr. Ramanjaneyulu K, J. Himabindhu
{"title":"Evaluation of In Vitro Anthelmintic Activity of Sesbania aculeata","authors":"I. Srikanth, K. Sai, G. Srihari, Dr. Ramanjaneyulu K, J. Himabindhu","doi":"10.47690/swjps.2019.1103","DOIUrl":"https://doi.org/10.47690/swjps.2019.1103","url":null,"abstract":"","PeriodicalId":109285,"journal":{"name":"SCIENCE WORLD JOURNAL OF PHARMACEUTICAL SCIENCES","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134035530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical uses of Cerebrolysin in Pediatric Neuropsychiatry 脑溶血素在小儿神经精神病学中的临床应用
SCIENCE WORLD JOURNAL OF PHARMACEUTICAL SCIENCES Pub Date : 1900-01-01 DOI: 10.47690/SWJPS.2020.1104
Aamir Jalal Al-Mosawi
{"title":"Clinical uses of Cerebrolysin in Pediatric Neuropsychiatry","authors":"Aamir Jalal Al-Mosawi","doi":"10.47690/SWJPS.2020.1104","DOIUrl":"https://doi.org/10.47690/SWJPS.2020.1104","url":null,"abstract":"INTRODUCTION In 1949, Austrian scientist Gerhart Harrer from the University of Innsbruck reported that the process of enzymatic hydrolysis of the brain tissue producing a protein-based liquid, cerebrolysin can stimulate nerve cells. Cerebrolysin which was probably first registered in Austria in 1954, and was also called (FPF1070) is a protein-based liquid mixture of free amino acids (85%) and 15% biologically active low molecular weight amino acid sequences which include low molecular weight neuro-peptides [1-5]: 1. Brain-derived neurotrophic factor. 2. Glial cell line-derived neurotrophic factor. 3. Nerve growth factor. 4. Ciliary neurotrophic factor. Cerebrolysin has been considered as a peptidergic substance with a multimodal mechanism of action. The active brain neuro-peptides contained in cerebrolysin penetrate the barrier of blood and brain and used by neurons to communicate with each other. The safety, tolerability, and efficacy of neuroreparative cerebrolysin therapy have been established in experimental studies and clinical trials. Cerebrolysin is associated with a relatively wide therapeutic time window [1-15]. Cerebrolysin acts as a neurotrophic and neuroprotective agent. This function may contribute delaying the progression of brain disorders [1-15]. Table 1 summarizes the mechanisms behind neuroreparative effects of cerebrolysin.","PeriodicalId":109285,"journal":{"name":"SCIENCE WORLD JOURNAL OF PHARMACEUTICAL SCIENCES","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131295275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书